110 related articles for article (PubMed ID: 18576238)
1. Stem cells and genetic testing: the gap between science and society widens.
Lewis R
Am J Bioeth; 2008 Apr; 8(4):1-3. PubMed ID: 18576238
[No Abstract] [Full Text] [Related]
2. Direct to confusion: lessons learned from marketing BRCA testing.
Matloff E; Caplan A
Am J Bioeth; 2008 Jun; 8(6):5-8. PubMed ID: 18726769
[TBL] [Abstract][Full Text] [Related]
3. DTC marketing of genetic tests: the perfect storm.
Chapman A
Am J Bioeth; 2008 Jun; 8(6):10-2. PubMed ID: 18726771
[No Abstract] [Full Text] [Related]
4. Advances in stem cell research for Amyotrophic Lateral Sclerosis.
Papadeas ST; Maragakis NJ
Curr Opin Biotechnol; 2009 Oct; 20(5):545-51. PubMed ID: 19819686
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing for vulnerable populations: what kinds of communication we need and do not need.
Schillinger D; Dohan D
Am J Bioeth; 2008 Jun; 8(6):12-4. PubMed ID: 18726772
[No Abstract] [Full Text] [Related]
6. Response to open peer commentaries on "Research 2.0: social networking and direct-to-consumer personal genomics".
Lee SS; Crawley L
Am J Bioeth; 2009; 9(6-7):W1-3. PubMed ID: 19998097
[No Abstract] [Full Text] [Related]
7. Why John Stuart Mill would support restriction on DTC marketing of genetic tests.
McGregor JL
Am J Bioeth; 2008 Jun; 8(6):9-10. PubMed ID: 18726770
[No Abstract] [Full Text] [Related]
8. Consumer alert: ethical issues raised by the sale of genetic tests directly to consumers.
Wasson K
Am J Bioeth; 2008 Jun; 8(6):16-8. PubMed ID: 18726774
[No Abstract] [Full Text] [Related]
9. Ask your doctor if this genetic test is right for you.
Brody H
Am J Bioeth; 2008 Jun; 8(6):1-2. PubMed ID: 18726765
[No Abstract] [Full Text] [Related]
10. Nerve cells made from elderly patient's skin cells.
Baker M
Nature; 2008 Aug; 454(7205):675. PubMed ID: 18685662
[No Abstract] [Full Text] [Related]
11. A pragmatic consideration of ethical issues relating to personal genomics.
Hsu AR; Mountain JL; Wojcicki A; Avey L
Am J Bioeth; 2009; 9(6-7):1-2. PubMed ID: 19998098
[No Abstract] [Full Text] [Related]
12. Genomics. Researchers to explore promise, risks of sequencing newborns' DNA.
Kaiser J
Science; 2013 Sep; 341(6151):1163. PubMed ID: 24030994
[No Abstract] [Full Text] [Related]
13. Redefining a technology: public and private genetic testing in Aotearoa New Zealand.
Scott A; Du Plessis R
Sociol Health Illn; 2008 Apr; 30(3):364-79. PubMed ID: 18194355
[TBL] [Abstract][Full Text] [Related]
14. [Cell therapy in amyotrophic lateral sclerosis: science and controversy].
Galán L; Guerrero-Sola A; Gómez-Pinedo U; Matias-Guiu J
Neurologia; 2010 Oct; 25(8):467-9. PubMed ID: 20964996
[TBL] [Abstract][Full Text] [Related]
15. Direct-to-consumer genetics and health policy: a worst-case scenario?
Caulfield T
Am J Bioeth; 2009; 9(6-7):48-50. PubMed ID: 19998115
[No Abstract] [Full Text] [Related]
16. Stem cells. CIRM awards seek to move cell therapies to the clinic.
Kaiser J
Science; 2009 Nov; 326(5954):780-1. PubMed ID: 19892950
[No Abstract] [Full Text] [Related]
17. Personalized medicine: an introduction to the ethical challenges.
Fleck LM
Urol Oncol; 2014 Feb; 32(2):186. PubMed ID: 24183192
[No Abstract] [Full Text] [Related]
18. [Cellular therapy in amyotrophic lateral sclerosis].
Matías-Guiu J; Barcia JA; García-Verdugo JM; Galán L; Vela A; García-Ramos R
Neurologia; 2008 May; 23(4):226-37. PubMed ID: 18307053
[TBL] [Abstract][Full Text] [Related]
19. A dive into the stem cells world.
Fagoonee S; Pellicano R; Altruda F
Panminerva Med; 2009 Mar; 51(1):1-3. PubMed ID: 19352304
[No Abstract] [Full Text] [Related]
20. Stem Cell Treatments.
Jin J
JAMA; 2017 Jan; 317(3):330. PubMed ID: 28114555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
